3

PRIMARY DOCUMENT

Company: ALNYLAM PHARMACEUTICALS, INC.
Filed: June 10, 2015
Period of Report: June 8, 2015
Accession Number: 0001325812-15-000050

View Document ↗ View on SEC.gov ↗